208 related articles for article (PubMed ID: 36357392)
1. An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons.
Krach F; Stemick J; Boerstler T; Weiss A; Lingos I; Reischl S; Meixner H; Ploetz S; Farrell M; Hehr U; Kohl Z; Winner B; Winkler J
Nat Commun; 2022 Nov; 13(1):6797. PubMed ID: 36357392
[TBL] [Abstract][Full Text] [Related]
2. An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.
Keller CG; Shin Y; Monteys AM; Renaud N; Beibel M; Teider N; Peters T; Faller T; St-Cyr S; Knehr J; Roma G; Reyes A; Hild M; Lukashev D; Theil D; Dales N; Cha JH; Borowsky B; Dolmetsch R; Davidson BL; Sivasankaran R
Nat Commun; 2022 Mar; 13(1):1150. PubMed ID: 35241644
[TBL] [Abstract][Full Text] [Related]
3. Meso scale discovery-based assays for the detection of aggregated huntingtin.
Reindl W; Baldo B; Schulz J; Janack I; Lindner I; Kleinschmidt M; Sedaghat Y; Thiede C; Tillack K; Schmidt C; Cardaun I; Schwagarus T; Herrmann F; Hotze M; Osborne GF; Herrmann S; Weiss A; Zerbinatti C; Bates GP; Bard J; Munoz-Sanjuan I; Macdonald D
PLoS One; 2019; 14(3):e0213521. PubMed ID: 30913220
[TBL] [Abstract][Full Text] [Related]
4. Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease.
Liu L; Malagu K; Haughan AF; Khetarpal V; Stott AJ; Esmieu W; Vater HD; Webster SJ; Van de Poël AJ; Clissold C; Cosgrove B; Sutton B; Spencer JA; Breccia P; Gancia E; Bonomo S; Ladduwahetty T; Lazari O; Patel H; Atton HC; Clifton S; Mota DM; Magnani D; O'Neill A; Stebbeds M; Macabuag N; Todd D; Herva ME; Mitchell P; Visser M; Compte Sancerni S; Grand Moursel L; da Silva M; Kritikou E; Heikkinen TT; Bolkvadze T; Fodale V; Spadafora D; Daldin M; Bresciani A; Mangette JE; Doherty EM; Lee MR; Herbst T; Monteagudo E; Macdonald D; Plotnikov NV; Chambers M; McAllister G; Muňoz-Sanjuan I; Dominguez C
J Med Chem; 2023 Sep; 66(18):13205-13246. PubMed ID: 37712656
[TBL] [Abstract][Full Text] [Related]
5. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
[TBL] [Abstract][Full Text] [Related]
6. Salivary Huntingtin protein is uniquely associated with clinical features of Huntington's disease.
Parkin GM; Corey-Bloom J; Snell C; Smith H; Laurenza A; Daldin M; Bresciani A; Thomas EA
Sci Rep; 2023 Jan; 13(1):1034. PubMed ID: 36658243
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
[TBL] [Abstract][Full Text] [Related]
8. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients.
Neueder A; Landles C; Ghosh R; Howland D; Myers RH; Faull RLM; Tabrizi SJ; Bates GP
Sci Rep; 2017 May; 7(1):1307. PubMed ID: 28465506
[TBL] [Abstract][Full Text] [Related]
9. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
10. Small molecule splicing modifiers with systemic HTT-lowering activity.
Bhattacharyya A; Trotta CR; Narasimhan J; Wiedinger KJ; Li W; Effenberger KA; Woll MG; Jani MB; Risher N; Yeh S; Cheng Y; Sydorenko N; Moon YC; Karp GM; Weetall M; Dakka A; Gabbeta V; Naryshkin NA; Graci JD; Tripodi T; Southwell A; Hayden M; Colacino JM; Peltz SW
Nat Commun; 2021 Dec; 12(1):7299. PubMed ID: 34911927
[TBL] [Abstract][Full Text] [Related]
11. Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues.
Hoschek F; Natan J; Wagner M; Sathasivam K; Abdelmoez A; von Einem B; Bates GP; Landwehrmeyer GB; Neueder A
Mol Med; 2024 Mar; 30(1):36. PubMed ID: 38459427
[TBL] [Abstract][Full Text] [Related]
12. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
[TBL] [Abstract][Full Text] [Related]
13. Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs.
Tong H; Yang T; Liu L; Li C; Sun Y; Jia Q; Qin Y; Chen L; Zhao X; Zhou G; Yan S; Li XJ; Li S
Neurobiol Dis; 2023 Oct; 187():106291. PubMed ID: 37716514
[TBL] [Abstract][Full Text] [Related]
14. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of σ
Jin J; Arbez N; Sahn JJ; Lu Y; Linkens KT; Hodges TR; Tang A; Wiseman R; Martin SF; Ross CA
ACS Chem Neurosci; 2022 Oct; 13(19):2852-2862. PubMed ID: 36108101
[TBL] [Abstract][Full Text] [Related]
16. Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease.
Schilling J; Broemer M; Atanassov I; Duernberger Y; Vorberg I; Dieterich C; Dagane A; Dittmar G; Wanker E; van Roon-Mom W; Winter J; Krauß S
J Mol Biol; 2019 Apr; 431(9):1869-1877. PubMed ID: 30711541
[TBL] [Abstract][Full Text] [Related]
17. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
[TBL] [Abstract][Full Text] [Related]
18. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.
Sathasivam K; Neueder A; Gipson TA; Landles C; Benjamin AC; Bondulich MK; Smith DL; Faull RL; Roos RA; Howland D; Detloff PJ; Housman DE; Bates GP
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2366-70. PubMed ID: 23341618
[TBL] [Abstract][Full Text] [Related]
19. Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain.
Petry S; Nateghi B; Keraudren R; Sergeant N; Planel E; Hébert SS; St-Amour I
Neuroscience; 2023 May; 518():54-63. PubMed ID: 35868517
[TBL] [Abstract][Full Text] [Related]
20. A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease.
Romo L; Mohn ES; Aronin N
J Huntingtons Dis; 2018; 7(2):101-108. PubMed ID: 29865084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
